Researchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for ...

A new study published in the New England Journal of Medicine has shown that a medication called abelacimab, when given as a subcutaneous injection (under the skin) is more effective than the ...

Milvexian is in three late-stage studies in AF, stroke, and acute coronary syndromes (ACS), while abelacimab is in the phase 3 LILAC-TIMI 76 in patients with AF deemed unsuitable for current OAC ...

John Friend, MD, CEO of Kazia Therapeutics added, "The novelty of the science that Professor Rao has proposed with this dual ...

The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the ...

Lupus, or systemic lupus erythematosus, often causes cutaneous lupus, leading to rashes, hair loss, and skin scarring. These rashes result from immune-driven inflammation. Standard treatment ...

Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science ...

Blackstone (NYSE: BX), the world’s largest alternative asset manager, is expanding its presence in the life sciences sector with a new multibillion-dollar fund dedicated to drug development. The firm ...

BELGRADE - Following a decision by President Aleksandar Vucic to pardon 13 people detained during protest blockades in the country, the Public Prosecutor's Office of Serbia will halt criminal ...

BELGRADE - Speaking to reporters after a meeting with Italian Deputy PM and FM Antonio Tajani, Serbian President Aleksandar Vucic said he was grateful to Tajani for visiting Belgrade at "an unpleasant ...